dyax corp
(DYAX:NASDAQ SE Consolidated Large Cap)
Executive Profile*
William E. Pullman MB BS, B Med Sc, Ph.D., FRACPFormer Chief Medical Officer, Senior Vice President and Member of Executive Team, Cubist Pharmaceuticals Inc. |
| Age | Total Calculated Compensation | This person is connected to 0 board members in 0 different organizations across 2 different industries. |
| 57 | -- |
Background*
Dr. William E. Pullman, MB BS, B Med Sc, PhD, FRACP served as an Executive Vice President of Dyax Corp. from October 2007 to March 13, 2012 and also served as its Chief Research & Development Officer until March 13, 2012. Dr. Pullman served as the Chief Development Officer of Dyax Corp. He served as Senior Vice President, Chief Medical Officer and Member of the Executive Team of Cubist Pharmaceuticals Inc. from May, 2006 to 2007. Dr. Pullman served as the Senior Vice ...
Corporate Headquarters*55 Network DriveBurlington, Massachusetts 01803 United States Phone: 617-225-2500 Fax: 617-225-2501 Board Members Memberships*There is no Board Members Memberships data available.Education*PhD Australian National University Unknown/Other Education The University of Western Australia
Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*There is no Total Compensation data available. |
| Recently Viewed | |||
| DYAX:US | $2.54 USD | +0.05 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Rick E. Winningham | Chairman, Chief Executive Officer, Member of Stock Option Committee and Member of Science & Technology Advisory Committee Theravance Inc. | $868.4K |
| Vincent J. Milano | Chairman, Chief Executive Officer and President ViroPharma Inc. | $645.0K |
| Carolyn J. Logan | Chief Executive Officer, President and Director Salix Pharmaceuticals Ltd. | $834.1K |
| Aijaz Tobaccowalla | Managing Director and Additional Director Wyeth Limited | -- |
| A. J. Kazimi MBA | Founder, Chairman, Chief Executive Officer and President Cumberland Pharmaceuticals, Inc. | $600.7K | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Thornton, CO | IntuitPosted: Apr 29
Sponsored Financial Commentaries
Sponsored Links
To contact DYAX CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
